K. Bichoupan

发表

High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV‐infected patients treated with sofosbuvir‐containing regimens

M. Woodward, A. Branch, D. Dieterich, 2016, Journal of viral hepatitis.

Re-re-treatment of hepatitis C virus: Eight patients who relapsed twice after direct-acting-antiviral drugs.

A. Branch, D. Dieterich, P. Perumalswami, 2015, World journal of gastroenterology.

MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy

V. Martel-Laferrière, D. Dieterich, K. Bichoupan, 2014, BMC Gastroenterology.

Costs of telaprevir‐based triple therapy for hepatitis C: $189,000 per sustained virological response

A. Branch, V. Martel-Laferrière, A. Moskowitz, 2014, Hepatology.

Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIV.

A. Branch, D. Dieterich, T. Schiano, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus

A. Branch, D. Dieterich, P. Perumalswami, 2016, PloS one.

Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir

A. Branch, V. Martel-Laferrière, D. Dieterich, 2014, Alimentary pharmacology & therapeutics.

The pharmacokinetic evaluation of boceprevir for treatment of Hepatitis C virus

D. Dieterich, H. Shankar, K. Bichoupan, 2013, Expert opinion on drug metabolism & toxicology.

Hepatitis C in HIV-Infected Patients: Impact of Direct-Acting Antivirals

D. Dieterich, K. Bichoupan, 2014, Drugs.

Pegylated-IFNα2a for HIV/hepatitis C virus coinfected patients: out with the old, in with the new

D. Dieterich, K. Bichoupan, 2014, Expert opinion on biological therapy.

A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants.

A. Branch, V. Martel-Laferrière, D. Ndiaye, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus.

A. Branch, S. Friedman, D. Dieterich, 2016, World journal of gastroenterology.

Virological response rates for telaprevir‐based hepatitis C triple therapy in patients with and without HIV coinfection

A. Branch, V. Martel-Laferrière, D. Dieterich, 2014, HIV medicine.

Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results

A. Branch, S. Friedman, D. Dieterich, 2017, World journal of virology.

Hepatitis C Direct-acting Antiviral Agents: Changing the Paradigm of Hepatitis C Treatment in HIV-infected Patients

V. Martel-Laferrière, D. Dieterich, K. Bichoupan, 2014, Journal of clinical gastroenterology.

Interferon-Free Regimens for Hepatitis C: Combine and Conquer

V. Martel-Laferrière, D. Dieterich, K. Bichoupan, 2014, BioDrugs.

Primary Care-Based Hepatitis C Treatment Outcomes With First-Generation Direct-Acting Agents

A. Branch, K. Sigel, K. Krauskopf, 2015, Journal of addiction medicine.

HIV-Hepatitis C Virus Co-infection in the era of Direct-Acting Antivirals

V. Martel-Laferrière, D. Dieterich, K. Bichoupan, 2014, Current HIV/AIDS Reports.

Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.

A. Branch, D. Dieterich, P. Perumalswami, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir‐based triple therapy

A. Branch, V. Martel-Laferrière, D. Dieterich, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Real-world experience of treating frozen shoulder using active manipulation under local anesthetic

K. Bichoupan, Keva Li, Kioomars Moosazadeh, 2021, Medicine.

Real World Experience of Drug Induced Liver Injury in Patients Undergoing Chemotherapy.

A. Branch, W. Oh, M. Galsky, 2018, Journal of clinical gastroenterology and hepatology.

795 REAL WORLD COSTS OF TELAPREVIR-BASED TRIPLE THERAPY, INCLUDING COSTS OF MANAGING ADVERSE EVENTS, AT THE MOUNT SINAI MEDICAL CENTER, NY: $147,000 PER EOT

A. Branch, V. Martel-Laferrière, D. Dieterich, 2013 .

Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis

Jasnit S. Makkar, A. Branch, T. Schiano, 2023, Cancer medicine.

Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection

A. Branch, V. Martel-Laferrière, D. Dieterich, 2017, World journal of hepatology.

Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study

A. Branch, V. Martel-Laferrière, T. Schiano, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Interferon-Free Regimens for Hepatitis C: Combine and Conquer

V. Martel-Laferrière, D. Dieterich, K. Bichoupan, 2014, BioDrugs.

A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants.

A. Branch, V. Martel-Laferrière, D. Ndiaye, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C Direct-acting Antiviral Agents: Changing the Paradigm of Hepatitis C Treatment in HIV-infected Patients

V. Martel-Laferrière, D. Dieterich, K. Bichoupan, 2014, Journal of clinical gastroenterology.

A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis.

K. Bichoupan, Alexis Pappas, Chip A. Bowman, 2024, Digestive diseases and sciences.

1137 EFFECTIVENESS OF HCV TRIPLE THERAPY WITH TELAPREVIR IN NEW YORK CITY

A. Branch, V. Martel-Laferrière, M. Vachon, 2012 .